Tumors with high NQO1 expression, such as hepatocellular carcinoma, pancreatic cancer, and breast cancer, are thus particularly sensitive to β-lapachone (Yang et al., 2017; Li et al., 2011; Zhao et al., 2021; Qadir et al., 2022). Here, NQO1 is linked to hepatocellular carcinoma.